Brief: Kontafarma China Says Shenzhen Stock Exchange Issued Notice Of Criticism Against Shenzhen Huakong Seg
25/04/2023 16:24
April 25 (Reuters) - Kontafarma China Holdings Ltd
1312.HK :
* RECENTLY NOTIFIED THAT SHENZHEN STOCK EXCHANGE ISSUED A
NOTICE
OF CRITICISM AGAINST, AMONG OTHERS, SHENZHEN HUAKONG SEG
* SZSE STATED HUAKONG SEG HAS NOT PERFORMED REVIEW
PROCEDURES AND
INFORMATION DISCLOSURE OBLIGATIONS OF RELATED PARTY TRANSACTIONS
* BOARD IS OF VIEW THAT THERE WILL NOT BE ANY MATERIAL
ADVERSE
IMPACT ON BUSINESS FROM DECISION
Source text for Eikon: ID:
Further company coverage: 1312.HK
Recent news on Kontafarma China Holdings
See all newsBrief: Kontafarma China Holdings Announces Creditors' Voluntary Winding-Up Of Singapore Subsidiaries
Brief: Kontafarma China Appoints Li Qingshan As Executive Director And President
Brief: Kontafarma China Sees HY Consol Net Loss Of HK$67.2 Million-HK$100.7 Million
Brief: Kontafarma China Appoints Wang Limin As Executive Director, Chairman And President
Brief: Kontafarma China Announces Resignation Of Liu Jiankun As Executive Director Effective 16 Apr